Articles From: Industry-First Automated RNP AR NavData Validation Service Introduced to InfoBionic Closes $17 Million Series B Financing; Names Steven R. Wasserman Chief Financial Officer and William R. Swavely Senior Vice President, IT


2014/10/14
Garmin International Inc. and Jeppesen, a part of Boeing Commercial Aviation Services, today introduced the RNP AR NavData Service, a new tool for pilots utilizing Required Navigation Performance – Authorization Required (RNP AR) procedures.
Sign-up for Industry-First Automated RNP AR NavData Validation Service Introduced investment picks
Reinforcing its commitment to making the driving experience safer, quieter and more sustainable, HARMAN, the premium global audio and infotainment group (NYSE:HAR), is expanding its HALOsonic suite of noise management solutions, which the company has co-developed with Lotus Engineering using patented Active Noise Control Technologies.
Sign-up for Industry-first: HARMAN Quiets the Car by Minimizing Road Noise investment picks
LAFAYETTE, La., Oct.
Sign-up for Industry-Leading Review Rates 124 LHC Group Home Health Locations Among Nation's Best investment picks
2014/11/19
TI receiver and transmitter system efficiently charges one- and two-cell battery-powered applications, supports any Qi-compatible 5-W wireless charging system DALLAS , Nov.
Sign-up for Industry's first 10-W wireless power solution allows consumers to charge faster and cooler without plugging in investment picks
TI's single-IC solution minimizes board space, accelerates design cycles and reduces audible noise by up to 75 percent DALLAS , Oct.
Sign-up for Industry's first 24-V, sinusoidal, sensorless, brushless DC motor driver quiets noise in fan and small pump applications investment picks
New TI ADC family provides flexibility and scalability with 12- and 14-bit, 2- and 4-channel, and JESD204B and LVDS options DALLAS , Sept.
Sign-up for Industry's lowest-power 25- to 160-MSPS analog-to-digital converter family saves energy in industrial designs investment picks
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, this week recognizes the 10 th anniversary of its unique Equinoxe ® Shoulder System .
Sign-up for Industry’s Fastest Growing Shoulder System Marks 10 Years of Improving Patient Outcomes investment picks
Software Defined Networking (SDN) and Network Function Virtualization (NFV) are taking on a dominant role in Cable and Telecom operator networks as they strive to lead the market and respond dynamically to subscribers’ needs for new services and applications.
Sign-up for Industry’s First Virtualized Ethernet Probe Offers Efficient, Scalable Testing and Diagnostics for Multi-Tenant Environments investment picks
2014/11/17
FRANKFURT--German semiconductor company Infineon Technologies AG (IFX.XE) on Monday extended the contract of Chief Executive Reinhard Ploss by five years until 2020.
Sign-up for Infineon Extends Contract of CEO Ploss by Five Years to 2020 investment picks
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Here's a look at some of the companies whose shares are making notable moves during European trade on Friday.
Sign-up for Infineon slides; Tryg rises: Europe's big stock moves investment picks
2014/10/13
Infineon Technologies AG (DE:IFX) was downgraded to neutral from overweight on Monday at J.P. Morgan Cazenove, which cited weakening demand both in Europe and China.
Sign-up for Infineon, STMicroeletronics downgraded at J.P. Morgan Cazenove investment picks
http://media.marketwire.com/attachments/201104/60146_infineralogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153238&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Infinera Corporation Reports Third Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201104/60146_infineralogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1144874&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Infinera Introduces Cloud Xpress for the Metro Cloud investment picks
2014/11/24
http://media.marketwire.com/attachments/201104/60146_infineralogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160846&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Infinera to Host Light on a Chip: The Future of Photonic Integration Webinar on December 10, 2014 investment picks
2014/10/18
By Dan Neil In the ivied precincts of Larchmont and Old Greenwich, there are driveways that must be served.
Sign-up for Infiniti crossover is a beast of suburban burden investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that new data for duvelisib (IPI-145), an oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, will be presented at the American Society of Hematology (ASH) 2014 Annual Meeting, which is being held December 6-9 in San Francisco, CA.
Sign-up for Infinity Announces Clinical and Preclincal Data for Duvelisib to Be Presented at ASH 2014 Annual Meeting investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Thursday, November 6, 2014, at 4:30 p.m. ET.
Sign-up for Infinity Announces the Date of Its Third Quarter 2014 Financial Results Conference Call and Webcast investment picks
Sessions designed to help Spanish-speaking individuals maneuver through the DMV and familiarize them with State vehicle insurance requirements LOS ANGELES , Nov.
Sign-up for Infinity Auto Insurance Hosts AB 60 Informational Workshops investment picks
BIRMINGHAM, Ala.
Sign-up for Infinity Property And Casualty Corporation Declares Quarterly Dividend investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported updated data from a Phase 1 monotherapy study of duvelisib (IPI-145), an inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma , which showed activity among patients with relapsed/refractory indolent non-Hodgkin lymphoma (iNHL), a fatal type of blood cancer.
Sign-up for Infinity Reports New Results from Phase 1 Study of Investigational Oncology Compound Duvelisib at the American Society of Hematology Annual Meeting investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today presented new preclinical translational data showing the complementary effects of inhibiting both PI3K-delta and PI3K-gamma , two enzymes known to play a role in regulating the growth and survival of certain types of potentially fatal blood cancers, including indolent non-Hodgkin lymphoma (iNHL) and chronic lymphocytic leukemia (CLL). This translational research also highlights the important role that PI3K-gamma plays in forming and maintaining the protective tumor microenvironment.
Sign-up for Infinity Reports New Translational Research and Updated Phase 1 Data of Investigational Oncology Compound Duvelisib at American Society of Hematology Annual Meeting investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported its third quarter 2014 financial results and updated its 2014 financial guidance based on the commencement of its global strategic collaboration with AbbVie Inc. to develop and commercialize duvelisib (IPI-145), an oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in oncology.
Sign-up for Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced encouraging topline data from its Phase 2a exploratory study of duvelisib (IPI-145), its oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with mild, allergic asthma.
Sign-up for Infinity Reports Topline Data from Phase 2a Exploratory Study of Duvelisib in Patients with Mild, Allergic Asthma investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following four upcoming conferences in November: A live webcast of Infinity's presentations at the Credit Suisse, Stifel and Goldman conferences will be accessible on the “investors/media” section of the company's website, www.infi.com , and will be available for 30 days following each event.
Sign-up for Infinity to Participate in Four Conferences in November investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Deutsche Bank Securities 2014 BioFEST Conference on December 1, 2014 at 2:15 p.m. ET in Boston.
Sign-up for Infinity to Present at the Deutsche Bank Securities 2014 BioFEST Conference investment picks
2014/9/29
Insurance firms are making a significant move toward private market assets to diversify against the risks that have traditionally underpinned their businesses, a new BlackRock-commissioned study of insurers with over $6.2 trillion of assets has found.
Sign-up for Inflation Risks and Thirst for Yield Drive Insurers to Private Markets investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Industry-First Automated RNP AR NavData Validation Service Introduced to InfoBionic Closes $17 Million Series B Financing; Names Steven R. Wasserman Chief Financial Officer and William R. Swavely Senior Vice President, IT
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent